Inventor · disambiguated record
Shouchun Liu
Also filed as: LIU SHOUCHUN
12 granted patents·4 pending applications·176 citations·filing 2005–2024
92Inventor score
Top patents by PatentIndex Score
16 records- 0198US10533053B2Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptorCYTOMX THERAPEUTICS INC·Filed 2016·Granted Jan 14, 2020·12 cites·20 claims
- 0298US9540440B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2014·Granted Jan 10, 2017·31 cites·25 claims
- 0397US10709799B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·10 cites·31 claims
- 0497US9889211B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2018·29 cites·52 claims
- 0597US9120853B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2013·Granted Sep 1, 2015·52 cites·43 claims
- 0696US9545442B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted Jan 17, 2017·19 cites·57 claims
- 0795US11180562B2Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodiesCYTOMX THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·5 cites·22 claims
- 0895US9856314B2Activatable antibodies having non-binding steric moieties and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2013·Granted Jan 2, 2018·15 cites·29 claims
- 0993US11890354B2Activatable antibodies that bind epidermal growth factor receptor and methods thereofCYTOMX THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·2 cites·16 claims
- 1092US12139543B2Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFRCYTOMX THERAPEUTICS INC·Filed 2021·Granted Nov 12, 2024·1 cites·25 claims
- 1191US2025215094A1Method of using an anti-epidermal growth factor receptor (egfr) activatable antibody to detect the presence or absence of a cleaving agent and egfrCYTOMX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1290US12502439B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Granted Dec 23, 2025·0 cites·20 claims
- 1371US2021309727A1Activatable antibodies having non-binding steric moieties and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1467US10894821B2Activatable antibodies having non-binding steric moieties and methods of using the sameCYTOMX THERAPEUTICS INC·Filed 2017·Granted Jan 19, 2021·0 cites·14 claims
- 1553US2024218317A1Application of bacillus velezensis in extraction of heparin from aquatic productUNIV GUANGDONG OCEAN·Filed 2022·Application pending·0 cites
- 1640US2005180949A1hC1Q/TNF7 and uses thereofNUVELO INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shouchun Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →